24-Hour Answering Services, Accepting New Patients, Back Pain, ...
Payment options:
American Express, Debit Cards, Discover, ...
Languages:
American Sign
Sliding scales:
NO
Accpepts insurance:
NO
Professional information
Jonathan M Licht, San Diego CA
Specialties:
Neurologist
Address:
4033 3Rd Ave, San Diego, CA 92103
Education:
Wayne State University, School of Medicine - Doctor of Medicine Henry Ford Hospital - Fellowship - Neuromuscular Medicine (Neurology) Henry Ford Hospital - Residency - Neurology University of California-Irvine Medical Center - Residency - Neurology Henry Ford Hospital - Internship - Flex
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Jonathan Licht, San Diego CA
Specialties:
Neurology, Physical Medicine & Rehabilitation
Work:
Neurology Medical Clinic 4033 3Rd Ave, San Diego, CA 92103
Education:
Wayne State University (1979)
Dr. Jonathan M Licht, San Diego CA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Jonathan M Licht MD 4033 3Rd Ave STE 206, San Diego 92103 (619) 294-9292 (Phone)
Certifications:
Neurology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Jonathan M Licht MD 4033 3Rd Ave STE 206, San Diego 92103 Scripps Mercy Hospital 4077 5Th Ave, San Diego 92103 Sharp Memorial Hospital 7901 Frost St, San Diego 92123
Education:
Medical School Wayne State University Graduated: 1979 Henry Ford Hospital U Calif Irvine
Jonathan Licht
Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Skills:
Neurology, Medical Affairs, Clinical Research, Pharmaceutical Industry, Public Speaking, Clinical Trials, Drug Development
Dextromethorphan And An Oxidase Inhibitor For Treating Intractable Conditions
US Patent:
RE38115, May 6, 2003
Filed:
Jan 18, 2002
Appl. No.:
10/052698
Inventors:
Richard Alan Smith - La Jolla CA Jonathan M. Licht - San Diego CA
Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction comprising administering dextromethorphan in combination with a therapeutically effective dosage of a debrisoquin hydroxylase inhibitor. A preferred combination is dextromethorphan and the oxidative inhibitor quinidine.
Dextromethorphan And An Oxidase Inhibitor For Treating Intractable Conditions
US Patent:
5863927, Jan 26, 1999
Filed:
Sep 19, 1996
Appl. No.:
8/464792
Inventors:
Richard Alan Smith - La Jolla CA Jonathan M. Licht - San Diego CA
Assignee:
Center for Neurologic Study - La Jolla CA
International Classification:
A61K 3144, A61K 31265, A61K 31135
US Classification:
514289
Abstract:
Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction comprising administering dextromethorphan in combination with a therapeutically effective dosage of a debrisoquin hydroxylase inhibitor. A preferred combination is dextromethorphan and the oxidative inhibitor quinidine.